Penumbra Financials

PEN Stock  USD 276.07  3.45  1.27%   
Based on the key measurements obtained from Penumbra's financial statements, Penumbra may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Penumbra's Other Current Assets are very stable compared to the past year. As of the 17th of March 2025, Other Stockholder Equity is likely to grow to about 1.2 B, while Common Stock Shares Outstanding is likely to drop about 35.4 M. Key indicators impacting Penumbra's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio6.686.0067
Moderately Up
Slightly volatile
The essential information of the day-to-day investment outlook for Penumbra includes many different criteria found on its balance sheet. An individual investor should monitor Penumbra's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Penumbra.

Cash And Equivalents

63.39 Million

  

Penumbra Earnings Geography

Penumbra Stock Summary

Penumbra competes with Insulet, TransMedics, Masimo, Inspire Medical, and InMode. Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people.
Specialization
Health Care, Health Care Equipment & Services
InstrumentUSA Stock View All
ExchangeNew York Stock Exchange
ISINUS70975L1070
CUSIP70975L107
LocationCalifornia; U.S.A
Business AddressOne Penumbra Place,
SectorHealth Care Equipment & Supplies
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.penumbrainc.com
Phone510 748 3200
CurrencyUSD - US Dollar

Penumbra Key Financial Ratios

Penumbra Key Balance Sheet Accounts

202020212022202320242025 (projected)
Total Assets823.0M1.2B1.4B1.6B1.5B820.4M
Other Current Liab79.8M89.8M85.2M103.6M112.4M60.9M
Other Liab15.3M8.0M3.6M3.3M3.8M3.6M
Net Debt7.6M114.2M165.9M66.9M(101.0M)(96.0M)
Retained Earnings40.6M45.9M43.9M134.9M60.0M31.1M
Accounts Payable14.1M13.4M26.7M27.2M31.3M32.9M
Cash69.7M59.4M69.9M167.5M324.4M340.6M
Other Assets34.3M138.1M78.7M77.0M88.6M47.4M
Net Receivables114.6M133.9M203.4M201.8M167.7M107.6M
Inventory219.5M263.5M334.0M388.0M406.7M427.1M
Other Current Assets18.7M29.2M30.3M36.4M36.6M38.4M
Total Liab185.2M290.3M372.0M377.4M382.3M205.5M
Total Current Assets617.7M681.5M755.7M915.4M951.1M537.5M
Common Stock34K35K36K37K38K39K
Net Tangible Assets449.3M622.5M696.9M751.7M864.4M459.5M
Good Will8.4M166.4M166.0M166.3M165.8M174.1M
Capital Surpluse430.7M598.3M910.6M963.0M1.1B583.1M
Intangible Assets10.6M90.6M81.2M63.2M6.5M6.2M
Long Term Debt Total26.7M27.1M26.5M24.9M28.6M16.5M

Penumbra Key Income Statement Accounts

202020212022202320242025 (projected)
Interest Expense17.4M16.1M137K1.7M1.4M1.3M
Total Revenue560.4M747.6M847.1M1.1B1.2B1.3B
Gross Profit338.2M475.4M535.2M682.6M755.0M792.7M
Operating Income(38.9M)(7.5M)(18.2M)73.6M9.3M6.3M
Ebit(38.9M)(7.5M)(21.5M)81.4M22.3M12.5M
Research Development90.0M104.6M79.4M84.4M94.8M55.6M
Ebitda(26.1M)8.9M6.1M112.0M46.0M23.9M
Cost Of Revenue222.2M272.2M311.9M375.9M439.6M461.6M
Income Before Tax50.1M(38.0M)(10.5M)79.7M20.9M21.9M
Net Income(19.3M)2.6M(2.0M)91.0M14.0M14.5M
Income Tax Expense(18.8M)(13.1M)5.9M(11.3M)6.9M7.2M
Tax Provision(18.8M)(13.1M)5.9M(11.3M)6.9M7.2M
Interest Income1.3M938K137K6.8M13.7M14.4M
Net Interest Income1.3M938K137K5.1M12.3M12.9M

Penumbra Key Cash Accounts

202020212022202320242025 (projected)
Change To Inventory(57.0M)(51.6M)(74.6M)(67.7M)43.7M45.8M
Change In Cash(3.1M)(10.3M)10.5M97.6M156.9M164.8M
Free Cash Flow(58.0M)(11.7M)(75.0M)82.1M147.3M154.7M
Depreciation12.9M16.4M24.3M27.3M23.7M24.9M
Other Non Cash Items17.6M9.2M5.0M26.8M100.9M106.0M
Capital Expenditures24.8M21.2M19.3M15.2M21.2M15.8M
Net Income(19.3M)2.6M(2.0M)91.0M14.0M15.1M
End Period Cash Flow69.7M59.4M69.9M167.5M324.4M340.6M
Investments(76.3M)(3.1M)74.1M(31.7M)77.6M81.5M
Net Borrowings(2.6M)(3.4M)(1.5M)(1.8M)(2.0M)(2.1M)
Change To Netincome(28.4M)24.3M57.2M43.6M50.1M52.6M
Change Receivables25.0M(8.3M)(21.3M)(69.9M)(62.9M)(59.7M)

Penumbra Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Penumbra's current stock value. Our valuation model uses many indicators to compare Penumbra value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Penumbra competition to find correlations between indicators driving Penumbra's intrinsic value. More Info.
Penumbra is rated below average in return on equity category among its peers. It is regarded fifth in return on asset category among its peers reporting about  4.03  of Return On Asset per Return On Equity. At this time, Penumbra's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Penumbra's earnings, one of the primary drivers of an investment's value.

Penumbra's Earnings Breakdown by Geography

Penumbra Systematic Risk

Penumbra's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Penumbra volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Penumbra correlated with the market. If Beta is less than 0 Penumbra generally moves in the opposite direction as compared to the market. If Penumbra Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Penumbra is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Penumbra is generally in the same direction as the market. If Beta > 1 Penumbra moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Penumbra Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Penumbra's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Penumbra growth as a starting point in their analysis.

Price Earnings To Growth Ratio

(7.33)

At this time, Penumbra's Price Earnings To Growth Ratio is very stable compared to the past year.

Penumbra March 17, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Penumbra help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Penumbra. We use our internally-developed statistical techniques to arrive at the intrinsic value of Penumbra based on widely used predictive technical indicators. In general, we focus on analyzing Penumbra Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Penumbra's daily price indicators and compare them against related drivers.
When determining whether Penumbra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Penumbra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Penumbra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Penumbra Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.37)
Earnings Share
0.35
Revenue Per Share
30.922
Quarterly Revenue Growth
0.108
Return On Assets
0.0484
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.